Remdesivir News and Research

RSS
Water-soluble vitamin E compounds directly inhibit SARS-CoV-2 replication and synergize with remdesivir

Water-soluble vitamin E compounds directly inhibit SARS-CoV-2 replication and synergize with remdesivir

Could corticosteroids increase mortality in COVID-19 patients without high oxygen supplementation?

Could corticosteroids increase mortality in COVID-19 patients without high oxygen supplementation?

Molecular dynamic analysis of SARS-CoV-2 inhibitors

Molecular dynamic analysis of SARS-CoV-2 inhibitors

Scientists identify existing drugs that may inhibit SARS-CoV-2 virus

Scientists identify existing drugs that may inhibit SARS-CoV-2 virus

Investigation reveals considerable added benefit of remdesivir for moderately ill COVID-19 patients

Investigation reveals considerable added benefit of remdesivir for moderately ill COVID-19 patients

Antibiotic clofoctol shows potential against SARS-CoV-2

Antibiotic clofoctol shows potential against SARS-CoV-2

The use of flavonoids as antiviral agents against SARS-CoV-2

The use of flavonoids as antiviral agents against SARS-CoV-2

Stool transplant may be worth exploring as treatment option for COVID-19

Stool transplant may be worth exploring as treatment option for COVID-19

Anti-malarial drug shows promise in the battle against COVID-19

Anti-malarial drug shows promise in the battle against COVID-19

Study provides important insights into early stages of SARS-CoV-2 infection

Study provides important insights into early stages of SARS-CoV-2 infection

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

Study suggests vitamin B12 as a SARS-CoV-2 antiviral

Study suggests vitamin B12 as a SARS-CoV-2 antiviral

Remdesivir caused dangerously low heart rate in COVID-19 patients

Remdesivir caused dangerously low heart rate in COVID-19 patients

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

Study finds no evidence for remdesivir's benefit in severe COVID-19 patients

Researchers review the origins of SARS-CoV-2 and present treatment methods

Researchers review the origins of SARS-CoV-2 and present treatment methods

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

What is the optimal dosing regimen for remdesivir in COVID-19 patients? A computational model

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

RedHill presents positive Phase 2 results for oral opaganib in patients with COVID-19 pneumonia

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Researchers prepare for next coronavirus pandemic

Researchers prepare for next coronavirus pandemic

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%

Anti-viral treatment can stop the spread of lab modeled SARS-CoV-2 by 99.5%